• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VII型胶原蛋白α1链:一种有前景的胰腺癌预后及免疫浸润生物标志物。

Collagen type VII α1 chain: A promising prognostic and immune infiltration biomarker of pancreatic cancer.

作者信息

Ding Cheng, Yu Zhangping, Li Xianliang, Zhu Jiqiao, Dai Menghua, He Qiang

机构信息

Department of Hepatobiliary Surgery, Beijing Chao-Yang Hospital Affiliated to Capital Medical University, Beijing 100020, P.R. China.

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, P.R. China.

出版信息

Oncol Lett. 2023 Jan 5;25(2):77. doi: 10.3892/ol.2023.13663. eCollection 2023 Feb.

DOI:10.3892/ol.2023.13663
PMID:36742365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9853101/
Abstract

Pancreatic cancer (PC) is a stubborn malignancy with high lethality and a low 5-year overall survival (OS) rate. Collagen type VII α1 chain (COL7A1), a major component of the extracellular matrix, serves important roles in numerous physiological processes and various illnesses. COL7A1 protein acts as an anchoring fibril between the external epithelial cells and the underlying stroma, and mutation of COL7A1 could cause recessive dystrophic epidermolysis bullosa. Raw data for PC were acquired from The Cancer Genome Atlas and the Gene Expression Omnibus database, and raw data for the normal pancreas were obtained from the Genotype-Tissue Expression database. COL7A1 mRNA expression in PC tissues was compared with that in either paired (GSE15471 dataset) or unpaired (all other data) normal pancreas tissues. The association between COL7A1 mRNA expression and clinicopathological factors was assessed using logistic regression analysis. Cox analysis and Kaplan-Meier analysis were used to evaluate the role of COL7A1 mRNA expression in prognosis and nomograms were constructed. Gene Ontology analysis, Kyoto Encyclopedia of Genes and Genomes analysis, Gene Set Enrichment Analysis (GSEA) and single-sample GSEA (ssGSEA) were performed to evaluate the relevant functions of COL7A1 and correlation with immune cell infiltration. Furthermore, reverse transcription-quantitative PCR was used to assess the mRNA expression levels of COL7A1 in PC. The present study demonstrated that COL7A1 mRNA expression was higher in PC tissues compared with in normal pancreas tissues. The Kaplan-Meier survival analysis indicated that patients with PC with high COL7A1 mRNA expression had shorter overall survival (OS), disease-specific survival (DSS) and progression-free interval (PFI) times compared with patients with PC with low COL7A1 mRNA expression. Multivariate analysis demonstrated that COL7A1 mRNA expression was an independent risk factor for OS, DSS and PFI. Nomogram and calibration plots were constructed to predict the prognosis of patients with PC. GSEA demonstrated that high mRNA expression levels of COL7A1 were associated with multiple cancer-related pathways. ssGSEA analysis indicated that COL7A1 expression was positively associated with natural killer CD56bright cells and T helper (Th)2 cells, and negatively associated with Th17 cells and eosinophils. The results of the present study suggested that COL7A1 could be an independent biomarker and an influential moderator of immune infiltration in PC.

摘要

胰腺癌(PC)是一种具有高致死率且5年总生存率(OS)较低的顽固性恶性肿瘤。Ⅶ型胶原蛋白α1链(COL7A1)是细胞外基质的主要成分,在众多生理过程和各种疾病中发挥重要作用。COL7A1蛋白作为外部上皮细胞与下方基质之间的锚定纤维,COL7A1的突变可导致隐性营养不良性大疱性表皮松解症。胰腺癌的原始数据来自癌症基因组图谱和基因表达综合数据库,正常胰腺的原始数据来自基因型-组织表达数据库。将胰腺癌组织中COL7A1 mRNA表达与配对(GSE15471数据集)或未配对(所有其他数据)的正常胰腺组织中的表达进行比较。使用逻辑回归分析评估COL7A1 mRNA表达与临床病理因素之间的关联。采用Cox分析和Kaplan-Meier分析评估COL7A1 mRNA表达在预后中的作用并构建列线图。进行基因本体分析、京都基因与基因组百科全书分析、基因集富集分析(GSEA)和单样本GSEA(ssGSEA)以评估COL7A1的相关功能及其与免疫细胞浸润的相关性。此外,采用逆转录定量PCR评估胰腺癌中COL7A1的mRNA表达水平。本研究表明,与正常胰腺组织相比,胰腺癌组织中COL7A1 mRNA表达更高。Kaplan-Meier生存分析表明,与COL7A1 mRNA表达低的胰腺癌患者相比,COL7A1 mRNA表达高的胰腺癌患者的总生存期(OS)、疾病特异性生存期(DSS)和无进展生存期(PFI)更短。多变量分析表明,COL7A1 mRNA表达是OS、DSS和PFI的独立危险因素。构建列线图和校准图以预测胰腺癌患者的预后。GSEA表明,COL7A1的高mRNA表达水平与多种癌症相关通路有关。ssGSEA分析表明,COL7A1表达与自然杀伤CD56bright细胞和辅助性T(Th)2细胞呈正相关,与Th17细胞和嗜酸性粒细胞呈负相关。本研究结果表明,COL7A1可能是胰腺癌中一种独立的生物标志物和免疫浸润的有影响的调节因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/320b67b238df/ol-25-02-13663-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/3822a63ae74c/ol-25-02-13663-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/b70139506f87/ol-25-02-13663-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/28d4fe405a6c/ol-25-02-13663-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/0a85259018d5/ol-25-02-13663-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/60536334bf96/ol-25-02-13663-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/3b52112594e7/ol-25-02-13663-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/320b67b238df/ol-25-02-13663-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/3822a63ae74c/ol-25-02-13663-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/b70139506f87/ol-25-02-13663-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/28d4fe405a6c/ol-25-02-13663-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/0a85259018d5/ol-25-02-13663-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/60536334bf96/ol-25-02-13663-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/3b52112594e7/ol-25-02-13663-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/9853101/320b67b238df/ol-25-02-13663-g06.jpg

相似文献

1
Collagen type VII α1 chain: A promising prognostic and immune infiltration biomarker of pancreatic cancer.VII型胶原蛋白α1链:一种有前景的胰腺癌预后及免疫浸润生物标志物。
Oncol Lett. 2023 Jan 5;25(2):77. doi: 10.3892/ol.2023.13663. eCollection 2023 Feb.
2
Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis.鉴定纤维连接蛋白 III 型结构域包含蛋白 3B 作为胰腺癌的一个潜在预后和治疗靶点:初步分析。
Eur J Med Res. 2024 Apr 5;29(1):221. doi: 10.1186/s40001-024-01823-6.
3
HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.HTRA3是一种预后生物标志物,与胃癌中的免疫浸润相关。
Front Oncol. 2020 Dec 23;10:603480. doi: 10.3389/fonc.2020.603480. eCollection 2020.
4
Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer.磷脂酶A/酰基转移酶4是一种预后生物标志物,与胰腺癌中的免疫浸润相关。
Heliyon. 2022 Aug 28;8(9):e10416. doi: 10.1016/j.heliyon.2022.e10416. eCollection 2022 Sep.
5
REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer.REEP3 是一种与胰腺癌免疫浸润相关的潜在诊断和预后生物标志物。
Sci Rep. 2024 Jun 15;14(1):13834. doi: 10.1038/s41598-024-64720-2.
6
Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.鉴定METTL18作为一种潜在的预后生物标志物及其与肝细胞癌免疫浸润的相关性。
Front Oncol. 2021 May 26;11:665192. doi: 10.3389/fonc.2021.665192. eCollection 2021.
7
PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas.PCGF1是一种预后生物标志物,与胶质瘤中的肿瘤免疫相关。
Ann Transl Med. 2022 Feb;10(4):227. doi: 10.21037/atm-22-198.
8
High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.高 MICAL-L2 表达及其在结肠腺癌预后中的作用。
BMC Cancer. 2022 May 2;22(1):487. doi: 10.1186/s12885-022-09614-0.
9
Characterization of mutations of the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa mitis (M-RDEB) from three Korean patients.三名韩国患者的隐性营养不良性大疱性表皮松解症轻型(M-RDEB)中VII型胶原蛋白基因(COL7A1)突变的特征分析。
J Dermatol Sci. 2001 Jun;26(2):125-32. doi: 10.1016/s0923-1811(00)00168-7.
10
Clinicopathological correlations of compound heterozygous COL7A1 mutations in recessive dystrophic epidermolysis bullosa.隐性营养不良型大疱性表皮松解症中复合杂合性COL7A1突变的临床病理相关性
J Invest Dermatol. 1996 Aug;107(2):171-7. doi: 10.1111/1523-1747.ep12329570.

引用本文的文献

1
Identification of Specific Biomarkers for Anaplastic Thyroid Carcinoma Through Spatial Transcriptomic and Immunohistochemical Profiling.通过空间转录组学和免疫组织化学分析鉴定间变性甲状腺癌的特异性生物标志物
Endocr Pathol. 2025 Apr 17;36(1):14. doi: 10.1007/s12022-025-09858-z.
2
indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma.表明其作为肺腺癌中一种与基底膜相关的预后生物标志物和治疗靶点具有关键潜力。
Front Pharmacol. 2025 Feb 14;16:1543193. doi: 10.3389/fphar.2025.1543193. eCollection 2025.
3
Establishment and characterization of mouse metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma organoids.

本文引用的文献

1
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.肿瘤微环境中癌症相关成纤维细胞与免疫细胞的串扰:新发现与未来展望。
Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1.
2
Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer.高表达 VII 型胶原(COL7A1)在胃癌患者中的预后价值。
Pathol Oncol Res. 2021 Aug 26;27:1609860. doi: 10.3389/pore.2021.1609860. eCollection 2021.
3
The Interplay between Dysregulated Ion Transport and Mitochondrial Architecture as a Dangerous Liaison in Cancer.
建立并鉴定代谢相关脂肪性肝炎相关肝细胞癌类器官小鼠模型。
Sci Rep. 2024 Nov 10;14(1):27460. doi: 10.1038/s41598-024-78963-6.
4
The COL7A1/PI3K/AKT axis regulates the progression of cholangiocarcinoma.COL7A1/PI3K/AKT轴调控胆管癌的进展。
Heliyon. 2024 Sep 7;10(18):e37361. doi: 10.1016/j.heliyon.2024.e37361. eCollection 2024 Sep 30.
5
COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage.COL7A1表达改善了透明细胞肾细胞癌患者分期之上的预后预测。
Cancers (Basel). 2023 May 10;15(10):2701. doi: 10.3390/cancers15102701.
离子转运失调与线粒体结构之间的相互作用:癌症中的危险关联
Int J Mol Sci. 2021 May 14;22(10):5209. doi: 10.3390/ijms22105209.
4
Pancancer survival analysis of cancer hallmark genes.泛癌生存分析癌症标志基因。
Sci Rep. 2021 Mar 15;11(1):6047. doi: 10.1038/s41598-021-84787-5.
5
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
6
NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype.胰腺癌中的自然杀伤细胞表现出细胞毒性受损和调节性白细胞介素-10表型。
Oncoimmunology. 2020 Nov 19;9(1):1845424. doi: 10.1080/2162402X.2020.1845424.
7
Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer.全球胰腺癌负担、风险因素及趋势。
Gastroenterology. 2021 Feb;160(3):744-754. doi: 10.1053/j.gastro.2020.10.007. Epub 2020 Oct 13.
8
High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection.高G2M通路评分的胰腺癌与较差的生存率相关,尤其是在切缘阳性(R1或R2)切除术后。
Cancers (Basel). 2020 Oct 6;12(10):2871. doi: 10.3390/cancers12102871.
9
The tumor microenvironment.肿瘤微环境。
Curr Biol. 2020 Aug 17;30(16):R921-R925. doi: 10.1016/j.cub.2020.06.081.
10
Regulation and modulation of antitumor immunity in pancreatic cancer.胰腺癌中的抗肿瘤免疫的调控与调节。
Nat Immunol. 2020 Oct;21(10):1152-1159. doi: 10.1038/s41590-020-0761-y. Epub 2020 Aug 17.